Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
107.81M | 98.23M | 75.44M | 52.37M | 55.22M | Gross Profit |
23.92M | 25.58M | 18.85M | 19.52M | 19.84M | EBIT |
1.89M | 5.96M | -769.00K | 8.91M | 7.42M | EBITDA |
22.43M | 25.82M | 15.34M | 24.95M | 19.59M | Net Income Common Stockholders |
-568.00K | 2.37M | -3.04M | 4.58M | 1.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
13.29M | 14.21M | 30.42M | 13.80M | 22.49M | Total Assets |
181.13M | 178.66M | 178.90M | 142.46M | 150.53M | Total Debt |
17.28M | 19.50M | 30.54M | 3.28M | 10.44M | Net Debt |
4.00M | 5.29M | 117.00K | -10.51M | -12.05M | Total Liabilities |
64.24M | 61.20M | 57.54M | 18.07M | 30.72M | Stockholders Equity |
116.89M | 117.46M | 121.35M | 124.39M | 119.81M |
Cash Flow | Free Cash Flow | |||
12.08M | -6.68M | 4.43M | -2.18M | -7.74M | Operating Cash Flow |
31.65M | 30.65M | 15.38M | 16.19M | 24.84M | Investing Cash Flow |
-18.88M | -36.97M | -10.68M | -17.32M | -32.36M | Financing Cash Flow |
-13.69M | -9.90M | 11.92M | -7.56M | -7.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$187.80M | 7.67 | 4.42% | 4.67% | 7.39% | 142.61% | |
74 Outperform | €7.96B | 9.08 | 5.21% | -3.06% | -24.51% | ||
66 Neutral | HK$21.43M | ― | -10.88% | ― | -7.51% | -5650.00% | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% | |
46 Neutral | €12.41B | ― | -6.64% | 2.39% | -35.35% | -14.20% | |
36 Underperform | HK$403.92M | ― | -16.42% | ― | -13.93% | 75.32% | |
31 Underperform | $151.86M | ― | ― | -69.69% | -9.41% |